Table of Contents
Hemp THC Banned: The Pot Politics
Checkout the full audio episode here at The Daily Dose Podcast
Key Take Away
- Immediate Implementation with Opposition: The DEA’s rule to categorize hemp THC as a Category I substance was implemented immediately, but it has faced strong opposition from the hemp and CBD industries, with expectations of significant litigation against the DEA.
- Limited Rescheduling for Certain CBD Drugs: While specific CBD drugs like Epidiolex have been rescheduled to Schedule V, allowing for prescription and pharmacy dispensing, this does not change the legal status of other CBD oil products, which remain classified as Schedule I substances by the DEA.
- Ongoing Review of Marijuana Rescheduling: The DEA is reviewing a recommendation to reschedule marijuana, potentially moving it from Schedule I to Schedule III, as part of a broader examination initiated by President Joe Biden’s executive order. This change could have significant implications for federal tax reforms and the advancement of federal marijuana reform efforts.
- No Clear Timeline for DEA’s Decision: Despite the ongoing review process, there is currently no definitive timeline for when the DEA will complete its evaluation and make a final decision on the rescheduling of marijuana.
- Complex Regulatory Landscape: The DEA’s actions reflect the intricate and contentious nature of drug scheduling and regulation in the U.S., highlighting ongoing debates about drug policy, the legal status of cannabis-related products, and the balance between regulation and access to substances with potential benefits.
My Thoughts
This came across my desk last night, many of you are already aware of and have used hemp based THC products. In fact I’ve spoken to many of you who have claimed you like it better than traditional cannabis due to the milder effect. In this episode I rant about the recent scheduling of Hemp THC Delta 8, 9 and THCo.
The DEA’s decision to potentially schedule hemp THC as a Category I substance has sparked significant discussion and controversy. The DEA’s rule, which immediately went into effect, has been met with a strong negative reaction from the hemp and CBD industries, with expectations of litigation against the DEA if the rule remains in place.
SUMMARY
The DEA’s immediate implementation of a rule classifying hemp THC as a Category I substance has met significant opposition and potential litigation from the hemp and CBD industries. Concurrently, the DEA is reviewing a recommendation to reschedule marijuana, a move that could bring substantial federal tax reforms and advance federal marijuana reform efforts, though the timeline for this decision remains unclear.
The News
The DEA a week ago announced the news to the public, it’s choice to schedule hemp THC products at the highest category came as a shock to many including myself. As I dove into the articles I couldn’t really find a reasonable explanation describing why this was necessary.
The legalization of cannabis has been the talk of the country for nearly 3+ years now. Hemp derived products have been protected by the Farm Bill of 2018 so what is the issue exactly. After digging around I threw my hands up and concluded there isn’t any logical reason provided by any of the articles released.
It’s important to note that while certain CBD drugs like Epidiolex have been moved to Schedule V, allowing them to be prescribed and dispensed through pharmacies, this rescheduling does not change the status of other CBD oil products.
The DEA continues to classify all other CBD products, besides Epidiolex, as Schedule I controlled substances, indicating they are considered to have no recognized medical benefit and a high potential for abuse.
The Info
As I continued to think about the overall decision it was clear to me anyway that the reason may very well be due to the increase in teen use, which shouldn’t be surprising. Furthermore it may have something to do with the supposed deaths from fake cannabis all of which fueled by an enormous black market.
Whatever the reason it’s a bad idea, how can we attempt to legalize cannabis state by state while traditional cannabis remains as a schedule 1 by the DEA and at the same time condemn hemp products to the same fate which cannabis suffered for nearly a century.
The powers that be need to really consider better laws, perhaps a decriminalization federally it would be the best decision all around for everyone, consumers and businesses alike. Banning products don’t work it fuels bigger and more violent black markets as we have seen throughout history.
I feel this decision wasn’t weighed properly by the DEA, choices like this only do harm to the broader cannabis culture. If cannabis is to be legalized then what’s the difference between hemp and cannabis. It seems as though the DEA made a preemptive move to clear the path of all competition for the advancement of cannabis legalization.
Furthermore, the DEA is currently reviewing a recommendation to reschedule marijuana, following President Joe Biden’s executive order for federal agencies to reexamine the drug’s status under U.S. law. The Department of Health and Human Services has suggested moving marijuana from Schedule I to Schedule III of the Controlled Substances Act.
Such a move would not only unlock significant federal tax reform for legal cannabis businesses but also likely advance other federal marijuana reform efforts. However, the timeline for the DEA’s review and a final decision is still unclear.
Conclusion: The Finer Details
This situation underscores the complex and often contentious landscape of drug scheduling and regulation in the United States, especially regarding substances derived from cannabis plants like hemp and marijuana.
The DEA’s decisions and the subsequent reactions from various stakeholders reflect broader debates about drug policy, the legal status of cannabis-related products, and the balance between regulation and access to potentially beneficial substances.
What do you think you should leave them down below.
Learn more about this article here Hemp THC Ban
FAQs
What does the DEA’s recent rule on hemp THC entail?
The DEA’s recent rule categorizes hemp THC as a Category I substance, indicating a high potential for abuse and no recognized medical benefit. This classification was implemented immediately but has faced strong opposition and potential litigation from the hemp and CBD industries.
How does the rescheduling of certain CBD drugs like Epidiolex affect other CBD products?
The rescheduling of specific CBD drugs like Epidiolex to Schedule V allows them to be prescribed by doctors and dispensed through pharmacies. However, this does not change the status of other CBD oil products, which remain as Schedule I controlled substances, considered illegal under federal law.
What is the significance of the DEA reviewing the rescheduling of marijuana?
The DEA’s review of the rescheduling of marijuana, potentially moving it from Schedule I to Schedule III, could lead to significant federal tax reform for legal cannabis businesses and advance other federal marijuana reform efforts. This process was initiated by President Joe Biden’s executive order to reexamine the drug’s status under U.S. law.
Is there a set timeline for the DEA to make a decision on the rescheduling of marijuana?
As of now, there is no definitive timeline for the DEA’s review process or for when a final decision on the rescheduling of marijuana will be made. The process involves careful consideration of various statutory and regulatory criteria, as well as scientific and medical evaluations.
What does the DEA’s action on hemp THC and the potential rescheduling of marijuana indicate about the regulatory landscape in the U.S.?
The DEA’s actions reflect the complex and often contentious landscape of drug scheduling and regulation in the United States. It highlights the broader debates about drug policy, the legal status of cannabis-related products, and the challenges in balancing regulation with access to potentially beneficial substances.
Sources:
- 420Intel: https://420intel.com/articles/2023/07/31/dea-head-pledges-seek-federal-marijuana-rescheduling-review-timeline-hhs
- MJBizDaily: https://mjbizdaily.com/dea-confirms-it-is-reviewing-marijuana-rescheduling-recommendation/
Related Articles:
- Cannabis News Now
- Why Is Delta 8 THC Legal And Sold Every Where
- Hemp THC Cannabinoids The End Is Near
- Cannabis Recall California Cannabis Corner
#deaban #hempthc #hempthcban #thclaws #cannabisnews #cannabisnewsnow #cannabiseducation #learnabouthempthc #whyhempthcwasbanned #stonertalk #420news #weedinfo #cannabisinfo #drugpolicy #cannabislaws #hemplaws #thedailydose
Meet The Author
